Alphagan: Clinical Trials

3 trials of Alphagan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Withdrawn 1

Follow Alphagan: new trials by email Literature Review of Alphagan trials Research Report on Alphagan

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brimonidine for Intraoperative Hemostasis
Brimonidine Topical - Dermatochalasis of Eyelid, Ptosis, Eyelid
Phase 4WithdrawnUniversity of Louisville2022-05-262025-01-15
The Effect of Brimonidine
Brimonidine, Tropicamide, Phenylephrine Ophthalmic Product - Intraocular Pressure
Phase 4CompletedWake Forest University Health Sciences132019-07-202024-02-01
Comparison of Istalolâ„¢ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Istalol and Optive, Alphagan - Ocular Hypertension, Open-Angle Glaucoma
Phase 4CompletedBp Consulting, Inc402008-06-012008-12-04

Conditions studied

Blepharoptosis (1)  ·  Ectropion (1)  ·  Entropion (1)  ·  Glaucoma, Open-Angle (1)  ·  Ocular Hypertension (1)

Sponsors

Bp Consulting, Inc (1)  ·  University of Louisville (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)

Top investigators

Christopher Compton, MD (1)  ·  Jason Bacharach, M.D (1)  ·  Keith Walter, MD (1)